To see all our publications in English, please click here

 

Download our overview brochure (6 p.)

 

About The OFDT

Mission

Established in 1993, the French Monitoring Centre for Drugs and Drug Addiction is a non-profit public interest group with a scientific mission. It disseminates scientifically validated information on drugs and drug addiction issues to public authorities, professionals working in the field and all concerned citizens. Its standing monitoring and survey system is built on in-house coordinated surveys as well as on other reliable sources on licit and illicit substances. The OFDT is also consulted for its expertise and methodology, for instance in providing information to help prepare governmental policies and in monitoring or assessing the implementation of public responses.

The OFDT documents many issues in the field of psychoactive substances and addictions. Who is using drugs? What are the kinds of drugs used and the prevalence of such use? Which substances are circulating? What are the related health and social consequences? What are the opinions and perceptions on drugs? What public responses have been developed to address these phenomena? How are the trafficking markets evolving? Since 2010, the OFDT has also been researching gambling issues.

The OFDT is the national referee or focal point for France within the European Information Network on Drugs and Drug Addiction (REITOX), coordinated by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). This European agency of the European Commission (decentralised in Lisbon) is responsible for supplying objective, reliable and comparable information on drugs and drug addiction phenomena and their consequences at a European level (www.emcdda.europa.eu).

From July 1st, 2020 the OFDT integrates new missions on gambling practices through the resumption of those of the French Monitoring Centre for Gambling.

Organisation

The tasks of the Centre are carried out by a team of experts and researchers from different disciplines (statistics, demographics, epidemiology, economics, medicine, pharmacology, sociology) as well as administrative and technical staff. The Head of the OFDT is Julien Morel d’Arleux, named in 2017 by the Management Board.

The Scientific Committee, chaired since 2012 by Bruno Falissard, advises and assists the Monitoring Centre; its members are scientists appointed in a personal capacity in view of their excellence in the areas falling within the scope of the OFDT’s missions.

The General Assembly, former Management Board, is chaired by Christine d'Autume, who was elected in 2017. It brings together representatives of the French state from the various Ministries involved in some way in the fight against drugs and drug addiction and the Interministerial Mission for Combating Drugs and Addictive Behaviours (MILDECA). It also includes people working in the spheres of public and private law. The OFDT is mainly funded by public grants from the MILDECA and through European credits.

What we do

All OFDT materials - survey reports, databases, various summary notes and statistical reports - are available to professionals and the general public on its website www.ofdt.fr.

Its data also include results from the general population surveys carried out by the OFDT (e.g., ESCAPAD, EROPP) and from its annual review of the trends among users based on a national monitoring scheme (TREND - SINTES).

Every two years, the OFDT updates Drugs, key data, a general overview with the most recent and detailed facts and figures. The Tendances informational letter provides policy makers, researchers and professionals with the latest knowledge in the field of drugs and drug addiction. Once a year, the OFDT publishes Drugs, international challenges, which deals with the drug supply and international illicit substance trafficking.

Several free access databases can also be consulted on the OFDT website, and in particular bibliographic and legislative databases and ODICER on Territorial indicators for information about drugs and drug addiction.

Drugs in Europe


2020 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2020 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2020

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.